ASM Clinical Microbiology Issues Update Invite - CDI

Appendix L4

ASM Clinical Microbiology Issues Update
Month, Year
Volume XX, Number
To read this newsletter on-line, go to:

PSAB ACTIVITIES










ASM Applauds FY 2015 Budget’s Increased Funding to Fight Antibiotic
Resistance
ASM Endorses American Cures Act of 2015
ASM and PASCV Issue Joint Statement on FDA’s LDT
ASM Participates in CDC Telebriefing on the Ebola Outbreak in West
Africa
ASM Attends December CCCLW Meeting
ASM Signs Implementation Letter on Combatting Antimicrobial
Resistance
ASM attends FDA Anti-Infective Drugs Advisory Committee Meeting
ASM Meets with Officials from WRAIR
Minority Microbiology Mentor Newsletter

ASM NEWS, JOURNAL ARTICLES AND UPDATES








C. difficile Laboratory Practice Survey
December Clinical Microbiology Portal Hot Topic
Clinical Microbiology Portal Q & A
ASM Conferences
ASM Journal Articles of Interest
ASM Press
Articles of Interest

FEDERAL AGENCY UPDATES

Appendix L4










FDA Grants First CLIA Waiver for Nucleic Acid-Based Flu Diagnostic
Test
Emergency Use Authorizations of In Vitro Diagnostic Devices for
Detection of Ebola Zaire Virus
Optimizing FDA’s Regulatory Oversight of Next Generation Sequencing
Diagnostic Tests
FDA Approves a Second Vaccine to Prevent serogroup B
Meningococcal Disease
FDA Approves New Antibacterial Drug Zerbaxa
FDA Approves Pathogen Reduction System to Treat Platelets
FDA Approves First Pathogen Reduction System to Treat Plasma
FDA Grants CLIA Waiver Expanding the Availability of Rapid Screening
Test for Syphilis
MMWR Articles of Interest

OTHER INFORMATION AND UPDATES


Articles of Interest

ASM NEWS, JOURNAL ARTICLES AND UPDATES
C. difficile Laboratory Practice Survey
The American Society for Microbiology (ASM) and the Centers for Disease
Control and Prevention (CDC) are conducting a survey to learn about
laboratories’ microbiological practices related to improving diagnosis and
management of patients with Clostridium difficile (C. difficile) infection. This
survey will take approximately 20 minutes to complete; participation is
voluntary. The results from the survey will be compiled and shared in
aggregate as a learning tool, presented at professional conferences and
potentially published in a professional journal in the field of laboratory science.
All information collected in this survey will be kept in a secure manner; your IP
address will NOT be retained.
If your laboratory has not yet participated in the survey, please visit
https://www.surveymonkey.com/s/M627S86 and complete it by (date to be
determined by OMB approval). Your feedback is important for guiding ASM
and CDC in their efforts to understand laboratory C. difficile practice. Contact
[email protected] with questions or concerns.

Appendix L4
American Society For Microbiology © 2015